Sanofi, which has moved purposefully into high technologies to get more from its manufacturing, will lean even more on that…More

Like many a corporate rejuvenation plan, CEO Paul Hudson’s blueprint for Sanofi includes some hefty cost cutting. The French drugmaker’s…More

Ready for a drug pricing showdown in the House of Representatives? Democrats plan to vote this week on House Speaker…More

Gilead and HHS have had a busy year in PrEP, including a patent lawsuit, but now they’re starting a program…More

The DOJ’s generics price fixing probe has been playing out for years, and this week authorities unveiled a new settlement…More

As lawmakers and the Trump administration debate drug pricing proposals, White House economic advisers have published unfavorable findings on House…More